Phase II trial of Nedaplatin/S-1/Cetuximab combination therapy for Recurrence or Metastatic Squamous cell carcinoma of the Head and Neck - Phase II trial of Nedaplatin/S-1/Cetuximab combination therapy for Recurrence or Metastatic Squamous cell carcinoma of the Head and Neck

Kinki University Faculty of Medicine, Department of Medical Oncology0 个研究点目标入组 40 人开始时间: 2013年8月16日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Prior systemic chemotherapy or radiotherapy which was completed more than 2 weeks prior to registration Current administration of Flucytosine Treated continuously with systemic steroids With history of severe drug allergy Massive pleural or pericardial effusion, ascites Known coronary artery disease, history of myocardial infarction within prior 6 Prior systemic chemotherapy or radiotherapy which was completed more than 2 weeks prior to registration Current administration of Flucytosine Treated continuously with systemic steroids With history of severe drug allergy Massive pleural or pericardial effusion, ascites Known coronary artery disease, history of myocardial infarction within prior 6 months or uncontrollable hypertension known cerebrovasucular disease within 6 months Active infection Continuous diarrhea Ileus or sub-ileus History of multiple cancers unless free of disease for at least five years Severe diabetes Positivity for hepatitis B surface antigen Severe psychotic disorder Pregnancy or breast feeding Other significant disease that in the investigator's opinion would exclude the subject from the trial

发起方

Kinki University Faculty of Medicine, Department of Medical Oncology